[Diversity in mechanism of angiotensin II production and application of the suppressive agents].
Miyazaki
Tamao
T
D000804:Angiotensin II / Q000096:biosynthesis* / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology; D053818:Chymases / Q000502:physiology; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000502:physiology; D012083:Renin / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D053818:Chymases; D012083:Renin